Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
By C. Bombardier, L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, R. Day, M. Ferraz, C. Hawkey, M. Hochberg and 2 more. New England Journal of Medicine, 2000
4,125 citations recorded by the source corpus.
Subfields: Pharmacology, Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/74216a9cc519184fbf00d9f4a75903b13687e8af
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Rheumatology
In Surgery
Citations in the corpus
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics (2006, background): “Physicians who act rationally and follow treatment guidelines will prescribe COX-2selective NSAIDs to patients with a history of GI irritation or hemorrhage;(14) this subgroup of NSAIDs has demonstrated reduced gastric side effects in randomized clinical trials (RCT).(15,16) Because these patients a”
- Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? (2008, background): “ies have been found to produce less gastrointestinal injury than conventional NSAIDs (23, 79, 163), nevertheless do cause significant gastrointestinal injury (105).”